Temporomandibular Joint Disorder Comorbidities.
Thomas DC, Khan J, Manfredini D, Ailani J.
Dent Clin North Am. 2023 Apr;67(2):379-392. doi: 10.1016/j.cden.2022.10.005. Epub 2023 Feb 1.
Temporomandibular Joint Disorder: An integrated study of the pathophysiology, neural mechanisms, and therapeutic strategies.
Lu G, Du R.
Arch Oral Biol. 2024 Aug;164:106001. doi: 10.1016/j.archoralbio.2024.106001. Epub 2024 May 14.
Low-level laser therapy in temporomandibular joint disorders: a systematic review.
Ahmad SA, Hasan S, Saeed S, Khan A, Khan M.
J Med Life. 2021 Mar-Apr;14(2):148-164. doi: 10.25122/jml-2020-0169.
Arthrofibrosis - a myth or true joint disorder?
Walocha A, Rutowicz B, Przybycień W, Zarzecki M, Kłosiński M, Depukat P, Solewski B, Mizia E, Gil A, Walocha E.
Folia Med Cracov. 2022 Jun 29;62(1):55-70. doi: 10.24425/fmc.2022.141691.
Sacroiliac joint imaging.
Tuite MJ.
Semin Musculoskelet Radiol. 2008 Mar;12(1):72-82. doi: 10.1055/s-2008-1067939.
Mucopolysaccharidoses.
Cimaz R, La Torre F.
Curr Rheumatol Rep. 2014 Jan;16(1):389. doi: 10.1007/s11926-013-0389-0.
Risk factors associated with temporomandibular joint disorder: A mendelian randomization analysis.
Yan Q, Liao L, He D.
J Oral Rehabil. 2024 Nov;51(11):2239-2247. doi: 10.1111/joor.13795. Epub 2024 Jul 23.
Temporomandibular joint disorder in a patient with multiple sclerosis--review of literature with a clinical report.
Badel T, Carek A, Podoreski D, Pavicin IS, Lovko SK.
Coll Antropol. 2010 Sep;34(3):1155-9.
Extraintestinal manifestations in inflammatory bowel disease - epidemiology, genetics, and pathogenesis.
Greuter T, Vavricka SR.
Expert Rev Gastroenterol Hepatol. 2019 Apr;13(4):307-317. doi: 10.1080/17474124.2019.1574569. Epub 2019 Feb 20.
Myhre syndrome.
Le Goff C, Michot C, Cormier-Daire V.
Clin Genet. 2014 Jun;85(6):503-13. doi: 10.1111/cge.12365. Epub 2014 Apr 2.
